These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24083422)

  • 1. Prognostic implications of changes in cardiac troponin I levels in patients with non-ST elevation acute coronary syndrome.
    Eggers KM; James S; Venge P; Lindahl B
    Biomarkers; 2013 Dec; 18(8):668-72. PubMed ID: 24083422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin I levels in patients with non-ST-elevation acute coronary syndrome-the importance of gender.
    Eggers KM; Johnston N; James S; Lindahl B; Venge P
    Am Heart J; 2014 Sep; 168(3):317-324.e1. PubMed ID: 25173543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.
    Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T
    Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
    Venge P; Johnston N; Lindahl B; James S
    J Am Coll Cardiol; 2009 Sep; 54(13):1165-72. PubMed ID: 19761938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of preoperative cardiac troponin I in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
    Thielmann M; Massoudy P; Neuhäuser M; Knipp S; Kamler M; Piotrowski J; Mann K; Jakob H
    Chest; 2005 Nov; 128(5):3526-36. PubMed ID: 16304309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
    Bonaca M; Scirica B; Sabatine M; Dalby A; Spinar J; Murphy SA; Jarolim P; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2010 May; 55(19):2118-24. PubMed ID: 20447535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36.
    Bonaca MP; O'Malley RG; Murphy SA; Jarolim P; Conrad MJ; Braunwald E; Sabatine MS; Morrow DA
    Eur Heart J Acute Cardiovasc Care; 2015 Oct; 4(5):431-40. PubMed ID: 25538086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    Circulation; 2007 Oct; 116(17):1907-14. PubMed ID: 17909103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, characteristics and outcomes of people aged 65 years and over with an incidental rise in cardiac troponin I. An observational prospective cohort study.
    Myint PK; Al-Jawad M; Chacko SM; Chu GS; Vowler SL; May HM
    Cardiology; 2008; 110(1):62-7. PubMed ID: 17934271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.
    Zdravkovic V; Mladenovic V; Colic M; Bankovic D; Lazic Z; Petrovic M; Simic I; Knezevic S; Pantovic S; Djukic A; Zdravkovic N
    Kardiol Pol; 2013; 71(5):472-9. PubMed ID: 23788087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
    Wilson SR; Sabatine MS; Braunwald E; Sloan S; Murphy SA; Morrow DA
    Am Heart J; 2009 Sep; 158(3):386-91. PubMed ID: 19699861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris.
    Gravning J; Ueland T; Mørkrid L; Endresen K; Aaberge L; Kjekshus J
    Scand Cardiovasc J; 2008 Jun; 42(3):214-21. PubMed ID: 18569954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
    Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
    Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes.
    Thielmann M; Massoudy P; Neuhäuser M; Tsagakis K; Marggraf G; Kamler M; Mann K; Erbel R; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I448-53. PubMed ID: 16820617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of platelet-monocyte aggregates with platelet activation, systemic inflammation, and myocardial injury in patients with non-st elevation acute coronary syndromes.
    Zhang SZ; Jin YP; Qin GM; Wang JH
    Clin Cardiol; 2007 Jan; 30(1):26-31. PubMed ID: 17262778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop study.
    Tajsic M; Járai R; Koch J; Stangl K; Wojta J; Dreger H; Huber K
    Int J Cardiol; 2018 Dec; 273():243-248. PubMed ID: 30282602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
    Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
    Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of glycogen phosphorylase isoenzyme BB is weak in the detection of patients with non-ST-elevation acute coronary syndrome.
    Meune C; Wahbi K; Weber S; Zuily S; Cynober L; Chenevier-Gobeaux C
    Clin Biochem; 2011 Nov; 44(16):1343-5. PubMed ID: 21820423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.